We believe in harnessing the power of the microbiome to unlock new therapeutic possibilities. Our mission is to develop off-the-shelf microbiome-based therapies that are highly effective, easy to administer, and capable of transforming the lives of patients worldwide.

The human gut and oral microbiome play crucial roles in modulating immune health, metabolism, and responses to therapies. While Fecal Microbiota Transplantation (FMT) has shown promising results across various diseases, logistical challenges have hindered widespread adoption. We see this as an opportunity to innovate and provide accessible solutions to patients in need.

Our approach involves an iterative framework of microbiota transplantation and research & development to identify key microbes, metabolites, and peptides driving therapeutic response. Through state-of-the-art DNA profiling techniques and genome engineering expertise, we aim to develop tailored therapies with maximal clinical efficacy.